# BioMarin Pharmaceutical, Inc. (NASDAQ: BMRN), Novato, CA – FDA Inspections

Source: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

> Inspection records and compliance data for BioMarin Pharmaceutical, Inc. in Novato, California. 12 FDA inspections on record, 1 Form 483, last inspected March 26, 2025. Publicly traded as NASDAQ: BMRN.

---

## Details

- Name: BioMarin Pharmaceutical, Inc.
- FEI Number: 3004079983
- Address Line 1: 46 Galli Dr
- City: Novato
- State: California
- Zip Code: 94949
- Country Name: United States
- Address: 46 Galli Dr, Novato, California 94949, United States
- Country: United States

## Stock

- Stock ticker: BMRN
- Exchange: NASDAQ
- Share price: $56.70
- Market cap: $11.0B
- Price as of: November 13, 2026

## Related Documents

- [483 - BioMarin Pharmaceutical, Inc. - Unknown Date](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/738d34c2-9e7c-4315-95b4-b0dcc2e07b20) — source: FDA, date: Invalid Date
- [483 - BioMarin Pharmaceutical, Inc. - 2026-06-09](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/3d9f6c03-46e4-4018-9f28-eb0298368c73) — source: FDA, date: June 9, 2026
- [FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/82d2a0af-f568-4ba0-b631-24e73e69b55a) — source: FDA, date: March 26, 2025
- FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26 — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2025
- [483 - BioMarin Pharmaceutical, Inc. - 2024-08-19](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/59238adc-e27c-4c98-954a-e756c73ea1ea) — source: FDA, date: August 19, 2024
- [FDA Inspection 1251795 - BioMarin Pharmaceutical, Inc. - 2024-08-19](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/e8b2b049-ebee-414e-99e1-b3ba421792a2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2024
- [EIR - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/1d79f65a-b3d4-47d3-b05d-e2df9c3252df) — source: FDA, date: April 2, 2021
- [483 - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/68119bf5-5042-4336-9c03-7fde3f113010) — source: FDA, date: April 2, 2021
- [483 - BioMarin Pharmaceutical, Inc. - 2020-05-28](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/1e97f714-134a-473e-8ca8-bbb33d74dfd1) — source: FDA, date: May 28, 2020
- [EIR - BioMarin Pharmaceutical, Inc. - 2018-11-09](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/d68114e4-98af-4ad9-9a84-ee2c914e8a3a) — source: FDA, date: November 9, 2018
- FDA Inspection 1076844 - BioMarin Pharmaceutical, Inc. - 2018-11-09 — source: FDA, date: November 9, 2018
- [EIR - BioMarin Pharmaceutical, Inc. - 2017-12-14](https://www.keypedia.com/records/eir/biomarin-pharmaceutical-inc/ed544e08-f6aa-4d9c-afdc-7ea7c99813dd) — source: FDA, date: December 14, 2017
- [FDA Inspection 1041169 - BioMarin Pharmaceutical, Inc. - 2017-12-14](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/294a4562-e09d-41ef-b5da-6e26860ddf6d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2017
- FDA Inspection 991276 - BioMarin Pharmaceutical, Inc. - 2016-11-04 — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2016
- [483 - BioMarin Pharmaceutical, Inc. - 2014-04-17](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/cae106c6-e26b-4552-bd9f-10fa67375f17) — source: FDA, date: April 17, 2014
- FDA Inspection 878935 - BioMarin Pharmaceutical, Inc. - 2014-04-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2014
- FDA Inspection 852996 - BioMarin Pharmaceutical, Inc. - 2013-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2013
- FDA Inspection 854766 - BioMarin Pharmaceutical, Inc. - 2013-06-28 — classification: No Action Indicated (NAI), source: FDA, date: June 28, 2013
- FDA Inspection 751754 - BioMarin Pharmaceutical, Inc. - 2011-11-03 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2011

## Related Companies

- [Nanjing Chengong Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nanjing-chengong-pharmaceutical-co-ltd/34bd5da4-2efe-4abc-9322-6847e76f7dda)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92)
- [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [Novartis Manufacturing LLC](https://www.keypedia.com/companies/novartis-manufacturing-llc/c4165663-ccb2-4abd-bba3-af6a0bdf462d)
- [STgen Bio Co., Ltd.](https://www.keypedia.com/companies/stgen-bio-co-ltd/bf0530c2-b747-4fce-ade6-52850415aac3)
- [Celltrion Inc.](https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/zhou-chen/03362438-eba1-4010-b6b1-5cccf25a824c)
- [recipient](https://www.keypedia.com/people/janet-hsu/31b3ec67-81e8-471e-b2f6-ed6af6a87cbd)
- [company_representative](https://www.keypedia.com/people/amy-kenner/058a4567-e4d3-4c7c-942c-06d6b0f9fe61)
- [company_representative](https://www.keypedia.com/people/victoria-sluzky/12846ad6-4449-434b-af7b-91c703b6a392)
- [Investigator](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)
